These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 24746933
1. Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE) in Alzheimer's disease. Schmidt FM, Mergl R, Stach B, Jahn I, Gertz HJ, Schönknecht P. Neurosci Lett; 2014 Jun 06; 570():81-5. PubMed ID: 24746933 [Abstract] [Full Text] [Related]
2. Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease? Palumbo B, Siepi D, Sabalich I, Tranfaglia C, Parnetti L. Funct Neurol; 2008 Jun 06; 23(2):93-6. PubMed ID: 18671910 [Abstract] [Full Text] [Related]
3. Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder. Schmidt FM, Mergl R, Stach B, Jahn I, Schönknecht P. World J Biol Psychiatry; 2015 Feb 06; 16(2):106-13. PubMed ID: 25264292 [Abstract] [Full Text] [Related]
4. Cerebrospinal fluid neuron-specific enolase is reduced in Alzheimer's disease. Cutler NR, Kay AD, Marangos PJ, Burg C. Arch Neurol; 1986 Feb 06; 43(2):153-4. PubMed ID: 3947256 [Abstract] [Full Text] [Related]
5. Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neuronal degeneration in dementia disorders? Blennow K, Wallin A, Ekman R. J Neural Transm Park Dis Dement Sect; 1994 Feb 06; 8(3):183-91. PubMed ID: 7748462 [Abstract] [Full Text] [Related]
6. The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease. Bahl JM, Heegaard NH, Falkenhorst G, Laursen H, Høgenhaven H, Mølbak K, Jespersgaard C, Hougs L, Waldemar G, Johannsen P, Christiansen M. Neurobiol Aging; 2009 Nov 06; 30(11):1834-41. PubMed ID: 18339451 [Abstract] [Full Text] [Related]
7. Cerebrospinal fluid neuron-specific enolase in Alzheimer's disease and vascular dementia. Parnetti L, Palumbo B, Cardinali L, Loreti F, Chionne F, Cecchetti R, Senin U. Neurosci Lett; 1995 Jan 02; 183(1-2):43-5. PubMed ID: 7746484 [Abstract] [Full Text] [Related]
8. Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease. Munroe WA, Southwick PC, Chang L, Scharre DW, Echols CL, Fu PC, Whaley JM, Wolfert RL. Ann Clin Lab Sci; 1995 Jan 02; 25(3):207-17. PubMed ID: 7605102 [Abstract] [Full Text] [Related]
9. Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls. Sundelöf J, Sundström J, Hansson O, Eriksdotter-Jönhagen M, Giedraitis V, Larsson A, Degerman-Gunnarsson M, Ingelsson M, Minthon L, Blennow K, Kilander L, Basun H, Lannfelt L. J Alzheimers Dis; 2010 Jan 02; 21(2):471-8. PubMed ID: 20555147 [Abstract] [Full Text] [Related]
10. MRI and CSF studies in the early diagnosis of Alzheimer's disease. de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Clark C, Kerkman D, DeBernardis J, Li J, Lair L, Reisberg B, Tsui W, Rusinek H. J Intern Med; 2004 Sep 02; 256(3):205-23. PubMed ID: 15324364 [Abstract] [Full Text] [Related]
11. [The measurement of phosphorylated tau in human cerebrospinal fluid as a diagnostic marker for Alzheimer's disease]. Urakami K, Ito N, Arai H, Ishiguro K, Ohno H, Nakashima K. Seishin Shinkeigaku Zasshi; 2003 Sep 02; 105(4):393-7. PubMed ID: 12806900 [Abstract] [Full Text] [Related]
12. CSF levels of the neuronal injury biomarker visinin-like protein-1 in Alzheimer's disease and dementia with Lewy bodies. Luo X, Hou L, Shi H, Zhong X, Zhang Y, Zheng D, Tan Y, Hu G, Mu N, Chan J, Chen X, Fang Y, Wu F, He H, Ning Y. J Neurochem; 2013 Dec 02; 127(5):681-90. PubMed ID: 23800322 [Abstract] [Full Text] [Related]
13. Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease. Arai H, Terajima M, Miura M, Higuchi S, Muramatsu T, Machida N, Seiki H, Takase S, Clark CM, Lee VM. Ann Neurol; 1995 Oct 02; 38(4):649-52. PubMed ID: 7574462 [Abstract] [Full Text] [Related]
14. Cerebrospinal fluid and serum neuron-specific enolase in acute benign headache. Casmiro M, Scarpa E, Cortelli P, Vignatelli L. Cephalalgia; 2008 May 02; 28(5):506-9. PubMed ID: 18294249 [Abstract] [Full Text] [Related]
15. CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment. Stefani A, Martorana A, Bernardini S, Panella M, Mercati F, Orlacchio A, Pierantozzi M. J Neurol Sci; 2006 Dec 21; 251(1-2):124-8. PubMed ID: 17097109 [Abstract] [Full Text] [Related]
16. Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia. Boban M, Grbić K, Mladinov M, Hof PR, Süssmair C, Ackl N, Stanić G, Bader B, Danek A, Simić G. Coll Antropol; 2008 Jan 21; 32 Suppl 1():31-6. PubMed ID: 18405055 [Abstract] [Full Text] [Related]
17. Clinical indications for analysis of Alzheimer's disease CSF biomarkers. Engelborghs S. Rev Neurol (Paris); 2013 Oct 21; 169(10):709-14. PubMed ID: 24016466 [Abstract] [Full Text] [Related]
18. Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults. Paternicò D, Galluzzi S, Drago V, Bocchio-Chiavetto L, Zanardini R, Pedrini L, Baronio M, Amicucci G, Frisoni GB. Alzheimers Dement; 2012 Nov 21; 8(6):520-7. PubMed ID: 22677492 [Abstract] [Full Text] [Related]
19. Increased cerebrospinal fluid levels of nerve cell biomarkers in narcolepsy with cataplexy. Heier MS, Skinningsrud A, Paus E, Gautvik KM. Sleep Med; 2014 Jun 21; 15(6):614-8. PubMed ID: 24784789 [Abstract] [Full Text] [Related]
20. Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an age-matched random sample. Ibach B, Binder H, Dragon M, Poljansky S, Haen E, Schmitz E, Koch H, Putzhammer A, Kluenemann H, Wieland W, Hajak G. Neurobiol Aging; 2006 Sep 21; 27(9):1202-11. PubMed ID: 16085339 [Abstract] [Full Text] [Related] Page: [Next] [New Search]